Calcium and Vitamin D to Optimize Bone Mass in Boys With Risperidone-induced Hyperprolactinemia
Clinical trial NCT00799383 · COMPLETED
Trial details
- NCT number
- NCT00799383
- Sponsor
- Chadi A. Calarge
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-11-01
- Primary completion
- 2014-03-01
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.